{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:17:41Z","timestamp":1788607061044,"version":"build-2803163510"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T00:00:00Z","timestamp":1718064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T00:00:00Z","timestamp":1718064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>According to a growing body of neurobiological evidence, the core symptoms of borderline personality disorder (BPD) may be linked to an opioidergic imbalance between the hedonic and stimulatory activity of mu opioid receptors (MOR) and the reward system inhibiting effects of kappa opioid receptors (KOR). Childhood trauma (CT), which is etiologically relevant to BPD, is also likely to lead to epigenetic and neurobiological adaptations by extensive activation of the stress and endogenous opioid systems. In this study, we investigated the methylation differences in the promoter of the KOR gene (<jats:italic>OPRK1<\/jats:italic>) in subjects with BPD (<jats:italic>N<\/jats:italic>\u2009=\u200947) and healthy controls (<jats:italic>N<\/jats:italic>\u2009=\u200948). Comparing the average methylation rates of regulatorily relevant subregions (specified regions CGI-1, CGI-2, EH1), we found no differences between BPD and HC. Analyzing individual CG nucleotides (<jats:italic>N<\/jats:italic>\u2009=\u2009175), we found eight differentially methylated CG sites, all of which were less methylated in BPD, with five showing highly interrelated methylation rates. This differentially methylated region (DMR) was found on the falling slope (5\u2019) of the promoter methylation gap, whose effect is enhanced by the DMR hypomethylation in BPD. A dimensional assessment of the correlation between disease severity and DMR methylation rate revealed DMR hypomethylation to be negatively associated with BPD symptom severity (measured by BSL-23). Finally, analyzing the influence of CT on DMR methylation, we found DMR hypomethylation to correlate with physical and emotional neglect in childhood (quantified by CTQ). Thus, the newly identified DMR may be a biomarker of the risks caused by CT, which likely epigenetically contribute to the development of BPD.<\/jats:p>","DOI":"10.1038\/s41380-024-02628-z","type":"journal-article","created":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T18:04:14Z","timestamp":1718129054000},"page":"3734-3741","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Differential methylation of OPRK1 in borderline personality disorder is associated with childhood trauma"],"prefix":"10.1038","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7655-5657","authenticated-orcid":false,"given":"Dorothee Maria","family":"Gescher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2748-9929","authenticated-orcid":false,"given":"Denny","family":"Schanze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8432-5459","authenticated-orcid":false,"given":"Peter","family":"Vavra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldine","family":"Zimmer-Bensch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1618-9269","authenticated-orcid":false,"given":"Martin","family":"Zenker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8113-6959","authenticated-orcid":false,"given":"Thomas","family":"Frodl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Schmahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,11]]},"reference":[{"key":"2628_CR1","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1016\/S0140-6736(21)00476-1","volume":"398","author":"M Bohus","year":"2021","unstructured":"Bohus M, Stoffers-Winterling J, Sharp C, Krause-Utz A, Schmahl C, Lieb K. Borderline personality disorder. Lancet. 2021;398:1528\u201340. https:\/\/doi.org\/10.1016\/S0140-6736(21)00476-1.","journal-title":"Lancet"},{"key":"2628_CR2","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1521\/pedi.2011.25.5.607","volume":"25","author":"MC Zanarini","year":"2011","unstructured":"Zanarini MC, Horwood J, Wolke D, Waylen A, Fitzmaurice G, Grant BF. Prevalence of DSM-IV borderline personality disorder in two community samples: 6,330 English 11-year-olds and 34,653 American adults. J Pers Disord. 2011;25:607\u201319. https:\/\/doi.org\/10.1521\/pedi.2011.25.5.607.","journal-title":"J Pers Disord"},{"key":"2628_CR3","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1521\/pedi.2010.24.4.412","volume":"24","author":"TJ Trull","year":"2010","unstructured":"Trull TJ, Jahng S, Tomko RL, Wood PK, Sher KJ. Revised NESARC personality disorder diagnoses: gender, prevalence, and comorbidity with substance dependence disorders. J Pers Disord. 2010;24:412\u201326. https:\/\/doi.org\/10.1521\/pedi.2010.24.4.412.","journal-title":"J Pers Disord"},{"key":"2628_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/2051-6673-1-12","volume":"1","author":"C Schmahl","year":"2014","unstructured":"Schmahl C, Herpertz SC, Bertsch K, Ende G, Flor H, Kirsch P, et al. Mechanisms of disturbed emotion processing and social interaction in borderline personality disorder: state of knowledge and research agenda of the German Clinical Research Unit. Borderline Personal Disord Emot Dysregul. 2014;1:12. https:\/\/doi.org\/10.1186\/2051-6673-1-12.","journal-title":"Borderline Personal Disord Emot Dysregul"},{"key":"2628_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.copsyc.2017.08.032","volume":"21","author":"SC Herpertz","year":"2018","unstructured":"Herpertz SC, Bertsch K, Jeung H. Neurobiology of criterion a: self and interpersonal personality functioning. Curr Opin Psychol. 2018;21:23\u20137. https:\/\/doi.org\/10.1016\/j.copsyc.2017.08.032.","journal-title":"Curr Opin Psychol"},{"key":"2628_CR6","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1037\/a0018095","volume":"117","author":"B Bandelow","year":"2010","unstructured":"Bandelow B, Schmahl C, Falkai P, Wedekind D. Borderline personality disorder: a dysregulation of the endogenous opioid system? Psychol Rev. 2010;117:623\u201336. https:\/\/doi.org\/10.1037\/a0018095.","journal-title":"Psychol Rev"},{"key":"2628_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2019.109782","volume":"98","author":"G Anderson","year":"2020","unstructured":"Anderson G. Pathoetiology and pathophysiology of borderline personality: Role of prenatal factors, gut microbiome, mu- and kappa-opioid receptors in amygdala-PFC interactions. Prog Neuropsychopharmacol Biol Psychiatry. 2020;98:109782. https:\/\/doi.org\/10.1016\/j.pnpbp.2019.109782.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2628_CR8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1651-2227.1994.tb13264.x","volume":"397","author":"J Panksepp","year":"1994","unstructured":"Panksepp J, Nelson E, Siviy S. Brain opioids and mother-infant social motivation. Acta Paediatr Suppl. 1994;397:40\u20136. https:\/\/doi.org\/10.1111\/j.1651-2227.1994.tb13264.x.","journal-title":"Acta Paediatr Suppl"},{"key":"2628_CR9","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.neuroscience.2003.11.011","volume":"124","author":"S Narayanan","year":"2004","unstructured":"Narayanan S, Lam H, Christian L, Levine MS, Grandy D, Rubinstein M, et al. Endogenous opioids mediate basal hedonic tone independent of dopamine D-1 or D-2 receptor activation. Neuroscience. 2004;124:241\u20136. https:\/\/doi.org\/10.1016\/j.neuroscience.2003.11.011.","journal-title":"Neuroscience"},{"key":"2628_CR10","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.bpsc.2020.10.013","volume":"6","author":"O Turtonen","year":"2021","unstructured":"Turtonen O, Saarinen A, Nummenmaa L, Tuominen L, Tikka M, Armio RL, et al. Adult attachment system links with brain mu-opioid receptor availability in vivo. Biol Psychiatry Cogn Neurosci Neuroimaging. 2021;6:360\u20139. https:\/\/doi.org\/10.1016\/j.bpsc.2020.10.013.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"2628_CR11","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.tins.2012.11.002","volume":"36","author":"PE Lutz","year":"2013","unstructured":"Lutz PE, Kieffer BL. Opioid receptors: distinct roles in mood disorders. Trends Neurosci. 2013;36:195\u2013206. https:\/\/doi.org\/10.1016\/j.tins.2012.11.002.","journal-title":"Trends Neurosci"},{"key":"2628_CR12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.brainres.2009.08.062","volume":"1314","author":"MR Bruchas","year":"2010","unstructured":"Bruchas MR, Land BB, Chavkin C. The dynorphin\/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors. Brain Res. 2010;1314:44\u201355. https:\/\/doi.org\/10.1016\/j.brainres.2009.08.062.","journal-title":"Brain Res"},{"key":"2628_CR13","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s00018-011-0844-x","volume":"69","author":"HA Tejeda","year":"2012","unstructured":"Tejeda HA, Shippenberg TS, Henriksson R. The dynorphin\/\u03ba-opioid receptor system and its role in psychiatric disorders. Cell Mol Life Sci. 2012;69:857\u201396. https:\/\/doi.org\/10.1007\/s00018-011-0844-x.","journal-title":"Cell Mol Life Sci"},{"key":"2628_CR14","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1523\/JNEUROSCI.4458-07.2008","volume":"28","author":"BB Land","year":"2008","unstructured":"Land BB, Bruchas MR, Lemos JC, Xu M, Melief EJ, Chavkin C. The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system. J Neurosci. 2008;28:407\u201314. https:\/\/doi.org\/10.1523\/JNEUROSCI.4458-07.2008.","journal-title":"J Neurosci"},{"key":"2628_CR15","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1176\/appi.ajp.2010.09091348","volume":"167","author":"AR Prossin","year":"2010","unstructured":"Prossin AR, Love TM, Koeppe RA, Zubieta JK, Silk KR. Dysregulation of regional endogenous opioid function in borderline personality disorder. Am J Psychiatry. 2010;167:925\u201333. https:\/\/doi.org\/10.1176\/appi.ajp.2010.09091348.","journal-title":"Am J Psychiatry"},{"key":"2628_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2800","volume":"36","author":"C Tim\u00e4us","year":"2021","unstructured":"Tim\u00e4us C, Meiser M, Wiltfang J, Bandelow B, Wedekind D. Efficacy of naltrexone in borderline personality disorder, a retrospective analysis in inpatients. Hum Psychopharmacol. 2021;36:e2800. https:\/\/doi.org\/10.1002\/hup.2800.","journal-title":"Hum Psychopharmacol"},{"key":"2628_CR17","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/YIC.0000000000000170","volume":"32","author":"A Martin-Blanco","year":"2017","unstructured":"Martin-Blanco A, Patrizi B, Soler J, Gasol X, Elices M, Gasol M, et al. Use of nalmefene in patients with comorbid borderline personality disorder and alcohol use disorder: a preliminary report. Int Clin Psychopharmacol. 2017;32:231\u20134. https:\/\/doi.org\/10.1097\/YIC.0000000000000170.","journal-title":"Int Clin Psychopharmacol"},{"key":"2628_CR18","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1176\/appi.ajp.2015.15040535","volume":"173","author":"Y Yovell","year":"2016","unstructured":"Yovell Y, Bar G, Mashiah M, Baruch Y, Briskman I, Asherov J, et al. Ultra-low-dose buprenorphine as a time-limited treatment for severe suicidal ideation: a randomized controlled trial. Am J Psychiatry. 2016;173:491\u20138. https:\/\/doi.org\/10.1176\/appi.ajp.2015.15040535.","journal-title":"Am J Psychiatry"},{"key":"2628_CR19","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00115-021-01239-1","volume":"93","author":"F Enning","year":"2022","unstructured":"Enning F, Schmahl C. Behandlung dissoziativer Symptome mit Nalmefen bei Patienten mit Borderline-Pers\u00f6nlichkeitsst\u00f6rung und komplexer posttraumatischer Belastungsst\u00f6rung [Treatment of dissociative symptoms with nalmefene in patients with borderline personality disorder and complex posttraumatic stress disorder]. Nervenarzt. 2022;93:503\u20135. https:\/\/doi.org\/10.1007\/s00115-021-01239-1.","journal-title":"Nervenarzt"},{"key":"2628_CR20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/YIC.0b013e32834d0e50","volume":"27","author":"C Schmahl","year":"2012","unstructured":"Schmahl C, Kleindienst N, Limberger M, Lud\u00e4scher P, Mauchnik J, Deibler P. Evaluation of naltrexone for dissociative symptoms in borderline personality disorder. Int Clin Psychopharmacol. 2012;27:61\u20138. https:\/\/doi.org\/10.1097\/YIC.0b013e32834d0e50.","journal-title":"Int Clin Psychopharmacol"},{"key":"2628_CR21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/s0193-953x(05)70145-3","volume":"23","author":"MC Zanarini","year":"2000","unstructured":"Zanarini MC. Childhood experiences associated with the development of borderline personality disorder. Psychiatr Clin North Am. 2000;23:89\u2013101. https:\/\/doi.org\/10.1016\/s0193-953x(05)70145-3.","journal-title":"Psychiatr Clin North Am"},{"key":"2628_CR22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s40479-022-00206-9","volume":"9","author":"A Schulze","year":"2022","unstructured":"Schulze A, Cloos L, Zdravkovic M, Lis S, Krause-Utz A. On the interplay of borderline personality features, childhood trauma severity, attachment types, and social support. Borderline Personal Disord Emot Dysregul. 2022;9:35. https:\/\/doi.org\/10.1186\/s40479-022-00206-9.","journal-title":"Borderline Personal Disord Emot Dysregul"},{"key":"2628_CR23","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00406-015-0612-2","volume":"266","author":"A Mart\u00edn-Blanco","year":"2016","unstructured":"Mart\u00edn-Blanco A, Ferrer M, Soler J, Arranz MJ, Vega D, Calvo N, et al. The role of hypothalamus-pituitary-adrenal genes and childhood trauma in borderline personality disorder. Eur Arch Psychiatry Clin Neurosci. 2016;266:307\u201316. https:\/\/doi.org\/10.1007\/s00406-015-0612-2.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2628_CR24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/s0193-953x(05)70146-5","volume":"23","author":"P Fonagy","year":"2000","unstructured":"Fonagy P, Target M, Gergely G. Attachment and borderline personality disorder. A theory and some evidence. Psychiatr Clin North Am. 2000;23:103\u201322. https:\/\/doi.org\/10.1016\/s0193-953x(05)70146-5.","journal-title":"Psychiatr Clin North Am"},{"key":"2628_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2018.29","volume":"4","author":"JG Gunderson","year":"2018","unstructured":"Gunderson JG, Herpertz SC, Skodol AE, Torgersen S, Zanarini MC. Borderline personality disorder. Nat Rev Dis Primers. 2018;4:18029. https:\/\/doi.org\/10.1038\/nrdp.2018.29.","journal-title":"Nat Rev Dis Primers"},{"key":"2628_CR26","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.copsyc.2020.09.010","volume":"37","author":"C Winsper","year":"2021","unstructured":"Winsper C. Borderline personality disorder: course and outcomes across the lifespan. Curr Opin Psychol. 2021;37:94\u20137. https:\/\/doi.org\/10.1016\/j.copsyc.2020.09.010.","journal-title":"Curr Opin Psychol"},{"key":"2628_CR27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1467-8624.2012.01793.x","volume":"84","author":"M Szyf","year":"2013","unstructured":"Szyf M, Bick J. DNA methylation: a mechanism for embedding early life experiences in the genome. Child Dev. 2013;84:49\u201357. https:\/\/doi.org\/10.1111\/j.1467-8624.2012.01793.x.","journal-title":"Child Dev"},{"key":"2628_CR28","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/nn1276","volume":"7","author":"IC Weaver","year":"2004","unstructured":"Weaver IC, Cervoni N, Champagne FA, D\u2019Alessio AC, Sharma S, Seckl JR, et al. Epigenetic programming by maternal behavior. Nat Neurosci. 2004;7:847\u201354. https:\/\/doi.org\/10.1038\/nn1276.","journal-title":"Nat Neurosci"},{"key":"2628_CR29","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.biopsych.2008.11.028","volume":"65","author":"TL Roth","year":"2009","unstructured":"Roth TL, Lubin FD, Funk AJ, Sweatt JD. Lasting epigenetic influence of early-life adversity on the BDNF gene. Biol Psychiatry. 2009;65:760\u20139. https:\/\/doi.org\/10.1016\/j.biopsych.2008.11.028.","journal-title":"Biol Psychiatry"},{"key":"2628_CR30","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.expneurol.2011.10.032","volume":"233","author":"C Heim","year":"2012","unstructured":"Heim C, Binder EB. Current research trends in early life stress and depression: review of human studies on sensitive periods, gene-environment interactions, and epigenetics. Exp Neurol. 2012;233:102\u201311. https:\/\/doi.org\/10.1016\/j.expneurol.2011.10.032.","journal-title":"Exp Neurol"},{"key":"2628_CR31","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1038\/nn.2436","volume":"12","author":"C Murgatroyd","year":"2009","unstructured":"Murgatroyd C, Patchev AV, Wu Y, Micale V, Bockmuhl Y, Fischer D, et al. Dynamic DNA methylation programs persistent adverse effects of early-life stress. Nat Neurosci. 2009;12:1559\u201366. https:\/\/doi.org\/10.1038\/nn.2436.","journal-title":"Nat Neurosci"},{"key":"2628_CR32","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.neuropharm.2014.01.013","volume":"80","author":"T Klengel","year":"2014","unstructured":"Klengel T, Pape J, Binder EB, Mehta D. The role of DNA methylation in stress-related psychiatric disorders. Neuropharmacology. 2014;80:115\u201332. https:\/\/doi.org\/10.1016\/j.neuropharm.2014.01.013.","journal-title":"Neuropharmacology"},{"key":"2628_CR33","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/npp.2012.149","volume":"38","author":"TY Zhang","year":"2013","unstructured":"Zhang TY, Labont\u00e9 B, Wen XL, Turecki G, Meaney MJ. Epigenetic mechanisms for the early environmental regulation of hippocampal glucocorticoid receptor gene expression in rodents and humans. Neuropsychopharmacology. 2013;38:111\u201323. https:\/\/doi.org\/10.1038\/npp.2012.149.","journal-title":"Neuropsychopharmacology"},{"key":"2628_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-022-02092-9","volume":"12","author":"L Malave","year":"2022","unstructured":"Malave L, van Dijk MT, Anacker C. Early life adversity shapes neural circuit function during sensitive postnatal developmental periods. Transl Psychiatry. 2022;12:306. https:\/\/doi.org\/10.1038\/s41398-022-02092-9.","journal-title":"Transl Psychiatry"},{"key":"2628_CR35","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/gbb.12197","volume":"14","author":"J Prados","year":"2015","unstructured":"Prados J, Stenz L, Courtet P, Prada P, Nicastro R, Adouan W, et al. Borderline personality disorder and childhood maltreatment: a genome-wide methylation analysis. Genes Brain Behav. 2015;14:177\u201388. https:\/\/doi.org\/10.1111\/gbb.12197.","journal-title":"Genes Brain Behav"},{"key":"2628_CR36","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1001\/archgenpsychiatry.2011.2287","volume":"69","author":"B Labont\u00e9","year":"2012","unstructured":"Labont\u00e9 B, Suderman M, Maussion G, Navaro L, Yerko V, Mahar I, et al. Genome-wide epigenetic regulation by early-life trauma. Arch Gen Psychiatry. 2012;69:722\u201331. https:\/\/doi.org\/10.1001\/archgenpsychiatry.2011.2287.","journal-title":"Arch Gen Psychiatry"},{"key":"2628_CR37","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.biopsych.2017.07.012","volume":"84","author":"PE Lutz","year":"2018","unstructured":"Lutz PE, Gross JA, Dhir SK, Maussion G, Yang J, Bramoulle A, et al. Epigenetic regulation of the kappa opioid receptor by child abuse. Biol Psychiatry. 2018;84:751\u201361. https:\/\/doi.org\/10.1016\/j.biopsych.2017.07.012.","journal-title":"Biol Psychiatry"},{"key":"2628_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2012.140","volume":"3","author":"N Perroud","year":"2013","unstructured":"Perroud N, Salzmann A, Prada P, Nicastro R, Hoeppli ME, Furrer S, et al. Response to psychotherapy in borderline personality disorder and methylation status of the BDNF gene. Transl Psychiatry. 2013;3:e207. https:\/\/doi.org\/10.1038\/tp.2012.140.","journal-title":"Transl Psychiatry"},{"key":"2628_CR39","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3390\/cells12030350","volume":"12","author":"E Jamshidi","year":"2023","unstructured":"Jamshidi E, Bostr\u00f6m AED, Wilczek A, Nilsonne \u00c5, \u00c5sberg M, Jokinen J. Increased Methylation of Brain-Derived Neurotrophic Factor (BDNF) Is related to emotionally unstable personality disorder and severity of suicide attempt in women. Cells. 2023;12:350. https:\/\/doi.org\/10.3390\/cells12030350.","journal-title":"Cells"},{"key":"2628_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2020.104784","volume":"120","author":"DA Moser","year":"2020","unstructured":"Moser DA, M\u00fcller S, Hummel EM, Limberg AS, Dieckmann L, Frach L, et al. Targeted bisulfite sequencing: a novel tool for the assessment of DNA methylation with high sensitivity and increased coverage. Psychoneuroendocrinology. 2020;120:104784. https:\/\/doi.org\/10.1016\/j.psyneuen.2020.104784.","journal-title":"Psychoneuroendocrinology"},{"key":"2628_CR41","doi-asserted-by":"publisher","first-page":"e0248514","DOI":"10.1371\/journal.pone.0248514","volume":"16","author":"V Flasbeck","year":"2021","unstructured":"Flasbeck V, Br\u00fcne M. Association between childhood maltreatment, psychopathology and DNA methylation of genes involved in stress regulation: evidence from a study in borderline personality disorder. PLoS One. 2021;16:e0248514. https:\/\/doi.org\/10.1371\/journal.pone.0248514.","journal-title":"PLoS One"},{"key":"2628_CR42","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jpsychires.2014.06.011","volume":"57","author":"A Marti\u0301n-Blanco","year":"2014","unstructured":"Marti\u0301n-Blanco A, Ferrer M, Soler J, Salazar J, Vega D, Andio\u0301n O, et al. Association between methylation of the glucocorticoid receptor gene, childhood maltreatment, and clinical severity in borderline personality disorder. J Psychiatr Res. 2014;57:34\u201340. https:\/\/doi.org\/10.1016\/j.jpsychires.2014.06.011.","journal-title":"J Psychiatr Res"},{"key":"2628_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2011.60","volume":"1","author":"N Perroud","year":"2011","unstructured":"Perroud N, Paoloni-Giacobino A, Prada P, Olie\u0301 E, Salzmann A, Nicastro R, et al. Increased methylation of glucocorticoid receptor gene (NR3C1) in adults with a history of childhood maltreatment: a link with the severity and type of trauma. Transl Psychiatry. 2011;1:e59. https:\/\/doi.org\/10.1038\/tp.2011.60.","journal-title":"Transl Psychiatry"},{"key":"2628_CR44","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.4161\/epi.6.12.18363","volume":"6","author":"G Dammann","year":"2011","unstructured":"Dammann G, Teschler S, Haag T, Altm\u00fcller F, Tuczek F, Dammann RH. Increased DNA methylation of neuropsychiatric genes occurs in borderline personality disorder. Epigenetics. 2011;6:1454\u201362. https:\/\/doi.org\/10.4161\/epi.6.12.18363.","journal-title":"Epigenetics"},{"key":"2628_CR45","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jpsychires.2013.10.003","volume":"48","author":"P Groleau","year":"2014","unstructured":"Groleau P, Joober R, Israel M, Zeramdini N, DeGuzman R, Steiger H. Methylation of the dopamine D2 receptor (DRD2) gene promoter in women with a bulimia-spectrum disorder: associations with borderline personality disorder and exposure to childhood abuse. J Psychiatr Res. 2014;48:121\u20137. https:\/\/doi.org\/10.1016\/j.jpsychires.2013.10.003.","journal-title":"J Psychiatr Res"},{"key":"2628_CR46","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/da.22406","volume":"33","author":"N Perroud","year":"2016","unstructured":"Perroud N, Zewdie S, Stenz L, Adouan W, Bavamian S, Prada P, et al. Methylation of serotonin receptor 3A in ADHD, Borderline Personality, and bipolar disorders: link with severity of the disorders and childhood maltreatment. Depress Anxiety. 2016;33:45\u201355. https:\/\/doi.org\/10.1002\/da.22406.","journal-title":"Depress Anxiety"},{"key":"2628_CR47","doi-asserted-by":"publisher","first-page":"e84180","DOI":"10.1371\/journal.pone.0084180","volume":"8","author":"S Teschler","year":"2013","unstructured":"Teschler S, Bartkuhn M, K\u00fcnzel N, Schmidt C, Kiehl S, Dammann G, et al. Aberrant methylation of gene associated CpG sites occurs in borderline personality disorder. PLoS ONE. 2013;8:e84180. https:\/\/doi.org\/10.1371\/journal.pone.0084180.","journal-title":"PLoS ONE"},{"key":"2628_CR48","doi-asserted-by":"publisher","first-page":"E67","DOI":"10.3390\/ijms17010067","volume":"17","author":"S Teschler","year":"2016","unstructured":"Teschler S, Gotthardt J, Dammann G, Dammann RH. Aberrant DNA Methylation of rDNA and PRIMA1 in borderline personality Disorder. Int J Mol Sci. 2016;17:E67. https:\/\/doi.org\/10.3390\/ijms17010067.","journal-title":"Int J Mol Sci"},{"key":"2628_CR49","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3389\/fpsyt.2018.00579","volume":"9","author":"DM Gescher","year":"2018","unstructured":"Gescher DM, Kahl KG, Hillemacher T, Frieling H, Kuhn J, Frodl T. Epigenetics in personality disorders: today\u2019s insights. Front Psychiatry. 2018;9:579. https:\/\/doi.org\/10.3389\/fpsyt.2018.00579.","journal-title":"Front Psychiatry"},{"key":"2628_CR50","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1006\/geno.1994.1117","volume":"19","author":"K Yasuda","year":"1994","unstructured":"Yasuda K, Espinosa R III, Takeda J, Le Beau MM, Bell GI. Localization of the kappa opioid receptor gene to human chromosome band 8q11.2. Genomics. 1994;19:596\u20137. https:\/\/doi.org\/10.1006\/geno.1994.1117.","journal-title":"Genomics"},{"key":"2628_CR51","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1097\/00008571-200412000-00002","volume":"14","author":"V Yuferov","year":"2004","unstructured":"Yuferov V, Fussell D, LaForge KS, Nielsen DA, Gordon D, Ho A, et al. Redefinition of the human kappa opioid receptor gene (OPRK1) structure and association of haplotypes with opiate addiction. Pharmacogenetics. 2004;14:793\u2013804. https:\/\/doi.org\/10.1097\/00008571-200412000-00002.","journal-title":"Pharmacogenetics"},{"key":"2628_CR52","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1101\/gad.2037511","volume":"25","author":"AM Deaton","year":"2011","unstructured":"Deaton AM, Bird A. CpG islands and the regulation of transcription. Genes Dev. 2011;25:1010\u201322. https:\/\/doi.org\/10.1101\/gad.2037511.","journal-title":"Genes Dev"},{"key":"2628_CR53","doi-asserted-by":"publisher","first-page":"4597","DOI":"10.1074\/jbc.M005477200","volume":"276","author":"X Hu","year":"2001","unstructured":"Hu X, Bi J, Loh HH, Wei LN. An intronic Ikaros-binding element mediates retinoic acid suppression of the kappa opioid receptor gene, accompanied by histone deacetylation on the promoters. J Biol Chem. 2001;276:4597\u2013603. https:\/\/doi.org\/10.1074\/jbc.M005477200.","journal-title":"J Biol Chem"},{"key":"2628_CR54","volume-title":"Assessment and diagnosis of personality disorders: The ICD-10 international personality disorder examination (IPDE).","year":"1997","unstructured":"Loranger AW, Janca A, Sartorius N, editors. Assessment and diagnosis of personality disorders: The ICD-10 international personality disorder examination (IPDE). Cambridge: Cambridge: Cambridge University Press; 1997."},{"key":"2628_CR55","volume-title":"Structured clinical interview for DSM-IV.","author":"HU Wittchen","year":"1997","unstructured":"Wittchen HU, Zaudig M, Fydrich T. Structured clinical interview for DSM-IV. G\u00f6ttingen: Hogrefe; 1997."},{"key":"2628_CR56","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000173701","volume":"42","author":"M Bohus","year":"2009","unstructured":"Bohus M, Kleindienst N, Limberger MF, Stieglitz RD, Domsalla M, Chapman AL, et al. The short version of the borderline symptom list (BSL-23): development and initial data on psychometric properties. Psychopathology. 2009;42:32\u20139. https:\/\/doi.org\/10.1159\/000173701.","journal-title":"Psychopathology"},{"key":"2628_CR57","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/pmh.1302","volume":"9","author":"MC Zanarini","year":"2015","unstructured":"Zanarini MC, Weingeroff JL, Frankenburg FR, Fitzmaurice GM. Development of the self-report version of the zanarini rating scale for borderline personality disorder. Personal Ment Health. 2015;9:243\u20139. https:\/\/doi.org\/10.1002\/pmh.1302.","journal-title":"Personal Ment Health"},{"key":"2628_CR58","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1023\/A:1024457819547","volume":"11","author":"C Spitzer","year":"1998","unstructured":"Spitzer C, Freyberger HJ, Stieglitz RD, Carlson EB, Kuhn G, Magdeburg N, et al. Adaptation and psychometric properties of the German version of the Dissociative Experience Scale. J Trauma Stress. 1998;11:799\u2013809. https:\/\/doi.org\/10.1023\/A:1024457819547.","journal-title":"J Trauma Stress"},{"key":"2628_CR59","unstructured":"Barratt ES. Impulsiveness subtraits: arousal and information processing. In: Spence JT, Izard CE (eds.). Motivation, emotion and personality. (1985) Elsevier Science Publishers: New York, 1985, pp. 137\u201346."},{"key":"2628_CR60","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/s0145-2134(02)00541-0","volume":"27","author":"DP Bernstein","year":"2003","unstructured":"Bernstein DP, Stein JA, Newcomb MD, Walker E, Pogge D, Ahluvalia T, et al. Development and validation of a brief screening version of the childhood trauma questionnaire. Child Abuse Negl. 2003;27:169\u201390. https:\/\/doi.org\/10.1016\/s0145-2134(02)00541-0.","journal-title":"Child Abuse Negl"},{"key":"2628_CR61","first-page":"55","volume-title":"Childhood Trauma Questionnaire: A retrospective self-report.","author":"D Bernstein","year":"1998","unstructured":"Bernstein D, Fink L. Childhood Trauma Questionnaire: A retrospective self-report. 1998. San Antonio, TK: The Psychological Corporation; 1998. p. 55."},{"key":"2628_CR62","unstructured":"Andrews S. FastQC: A Quality Control Tool for High Throughput Sequence Data. 2010 Retrieved from: http:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc\/."},{"key":"2628_CR63","doi-asserted-by":"publisher","unstructured":"Krueger F, James F, Ewels P, Afyounian E, Schuster-Boeckler B. FelixKrueger\/TrimGalore: v0.6.7 - DOI via Zenodo (0.6.7). Zenodo. 2021. Retrieved from: https:\/\/doi.org\/10.5281\/zenodo.5127899.","DOI":"10.5281\/zenodo.5127899"},{"key":"2628_CR64","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1093\/bioinformatics\/btr167","volume":"27","author":"F Krueger","year":"2011","unstructured":"Krueger F, Andrews SR. Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications. Bioinformatics. 2011;27:1571\u20132. https:\/\/doi.org\/10.1093\/bioinformatics\/btr167.","journal-title":"Bioinformatics"},{"key":"2628_CR65","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B. 1995;57:289\u2013300. https:\/\/doi.org\/10.1111\/j.2517-6161.1995.tb02031.x.","journal-title":"J R Statist Soc B"},{"key":"2628_CR66","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.3892\/etm.2018.6514","volume":"16","author":"H Ji","year":"2018","unstructured":"Ji H, Liu G, Xu X, Liu H, Xu L, Hu H, et al. Hypermethylation of the \u03ba1 opioid receptor promoter in Chinese heroin and methamphetamine addicts. Exp Ther Med. 2018;16:2392\u20138. https:\/\/doi.org\/10.3892\/etm.2018.6514.","journal-title":"Exp Ther Med"},{"key":"2628_CR67","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1038\/npp.2015.138","volume":"40","author":"HA Tejeda","year":"2015","unstructured":"Tejeda HA, Hanks AN, Scott L, Mejias-Aponte C, Hughes ZA, O\u2019Donnell P. Prefrontal cortical kappa opioid receptors attenuate responses to amygdala inputs. Neuropsychopharmacology. 2015;40:2856\u201364. https:\/\/doi.org\/10.1038\/npp.2015.138.","journal-title":"Neuropsychopharmacology"},{"key":"2628_CR68","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1037\/mot0000135","volume":"6","author":"D Kyte","year":"2020","unstructured":"Kyte D, Jerram M, DiBiase R. Brain opioid theory of social attachment: a review of evidence for approach motivation to harm. Motivation Science. 2020;6:12\u201320. https:\/\/doi.org\/10.1037\/mot0000135.","journal-title":"Motivation Science"},{"key":"2628_CR69","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/s41591-020-0806-7","volume":"26","author":"AD Krystal","year":"2020","unstructured":"Krystal AD, Pizzagalli DA, Smoski M, Mathew SJ, Nurnberger J Jr, Lisanby SH, et al. A randomized proof-of-mechanism trial applying the \u2018fast-fail\u2019 approach to evaluating \u03ba-opioid antagonism as a treatment for anhedonia. Nat Med. 2020;26:760\u20138. https:\/\/doi.org\/10.1038\/s41591-020-0806-7.","journal-title":"Nat Med"},{"key":"2628_CR70","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders (5th ed.)","author":"American Psychiatric Association.","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders (5th ed.). 2013. Arlington, VA, Washington, D.C.: American Psychiatric Association; 2013."},{"key":"2628_CR71","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/mp.2014.1","volume":"19","author":"O Chelnokova","year":"2014","unstructured":"Chelnokova O, Laeng B, Eikemo M, Riegels J, L\u00f8seth G, Maurud H, et al. Rewards of beauty: the opioid system mediates social motivation in humans. Mol Psychiatry. 2014;19:746\u20137. https:\/\/doi.org\/10.1038\/mp.2014.1.","journal-title":"Mol Psychiatry"},{"key":"2628_CR72","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.39648","volume":"7","author":"C Buchel","year":"2018","unstructured":"Buchel C, Miedl S, Sprenger C. Hedonic processing in humans is mediated by an opioidergic mechanism in a mesocorticolimbic system. Elife. 2018;7:e39648. https:\/\/doi.org\/10.7554\/eLife.39648.","journal-title":"Elife"},{"key":"2628_CR73","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.neubiorev.2020.12.013","volume":"121","author":"IM Meier","year":"2021","unstructured":"Meier IM, van Honk J, Bos PA, Terburg D. A mu-opioid feedback model of human social behavior. Neurosci Biobehav Rev. 2021;121:250\u20138. https:\/\/doi.org\/10.1016\/j.neubiorev.2020.12.013.","journal-title":"Neurosci Biobehav Rev"},{"key":"2628_CR74","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jad.2009.10.028","volume":"124","author":"B Stanley","year":"2010","unstructured":"Stanley B, Sher L, Wilson S, Ekman R, Huang YY, Mann JJ. Non-suicidal self-injurious behavior, endogenous opioids and monoamine neurotransmitters. J Affect Disord. 2010;124:134\u201340. https:\/\/doi.org\/10.1016\/j.jad.2009.10.028.","journal-title":"J Affect Disord"},{"key":"2628_CR75","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jad.2020.09.036","volume":"278","author":"P van der Venne","year":"2021","unstructured":"van der Venne P, Balint A, Drews E, Parzer P, Resch F, Koenig J, et al. Pain sensitivity and plasma beta-endorphin in adolescent non-suicidal self-injury. J Affect Disord. 2021;278:199\u2013208. https:\/\/doi.org\/10.1016\/j.jad.2020.09.036.","journal-title":"J Affect Disord"},{"key":"2628_CR76","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/s41386-020-00914-2","volume":"46","author":"LM St\u00f6rkel","year":"2021","unstructured":"St\u00f6rkel LM, Karabatsiakis A, Hepp J, Kolassa IT, Schmahl C, Niedtfeld I. Salivary beta-endorphin in nonsuicidal self-injury: an ambulatory assessment study. Neuropsychopharmacology. 2021;46:1357\u201363. https:\/\/doi.org\/10.1038\/s41386-020-00914-2.","journal-title":"Neuropsychopharmacology"},{"key":"2628_CR77","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jad.2019.01.025","volume":"248","author":"A Amad","year":"2019","unstructured":"Amad A, Ramoz N, Peyre H, Thomas P, Gorwood P. FKBP5 gene variants and borderline personality disorder. J Affect Disord. 2019;248:26\u20138.","journal-title":"J Affect Disord"},{"key":"2628_CR78","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.euroneuro.2019.09.011","volume":"29","author":"M Thomas","year":"2019","unstructured":"Thomas M, Banet N, Wallisch A, Glowacz K, Becker-Sadzio J, Gundel F, et al. Differential COMT DNA methylation in patients with borderline personality disorder: genotype matters. Eur Neuropsychopharmacol. 2019;29:1295\u20131300. https:\/\/doi.org\/10.1016\/j.euroneuro.2019.09.011.","journal-title":"Eur Neuropsychopharmacol"},{"key":"2628_CR79","doi-asserted-by":"publisher","first-page":"e23658","DOI":"10.1371\/journal.pone.0023658","volume":"7","author":"C Schmahl","year":"2012","unstructured":"Schmahl C, Lud\u00e4scher P, Greffrath W, Kraus A, Valerius G, Schulze TG, et al. COMT val158met polymorphism and neural pain processing. PLoS ONE. 2012;7:e23658. https:\/\/doi.org\/10.1371\/journal.pone.0023658.","journal-title":"PLoS ONE"},{"key":"2628_CR80","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.neubiorev.2014.01.003","volume":"40","author":"A Amad","year":"2014","unstructured":"Amad A, Ramoz N, Thomas P, Jardri R, Gorwood P. Genetics of borderline personality disorder: systematic review and proposal of an integrative model. Neurosci Biobehav Rev. 2014;40:6\u201319. https:\/\/doi.org\/10.1016\/j.neubiorev.2014.01.003.","journal-title":"Neurosci Biobehav Rev"},{"key":"2628_CR81","doi-asserted-by":"publisher","first-page":"343","DOI":"10.9758\/cpn.2017.15.4.343","volume":"15","author":"NJ Kolla","year":"2017","unstructured":"Kolla NJ, Meyer J, Sanches M, Charbonneau J. Monoamine oxidase- a genetic variants and childhood abuse predict impulsiveness in borderline personality disorder. Clin Psychopharmacol Neurosci. 2017;15:343\u201351.","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"2628_CR82","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s12888-020-02710-0","volume":"20","author":"M Zhang","year":"2020","unstructured":"Zhang M, Liu N, Chen H, Zhang N. Oxytocin receptor gene, childhood maltreatment and borderline personality disorder features among male inmates in China. BMC Psychiatry. 2020;20:332.","journal-title":"BMC Psychiatry"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-024-02628-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-024-02628-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-024-02628-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:04:52Z","timestamp":1733097892000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-024-02628-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,11]]},"references-count":82,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["2628"],"URL":"https:\/\/doi.org\/10.1038\/s41380-024-02628-z","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,11]]},"assertion":[{"value":"19 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}